JNA
MCID: JVN033
MIFTS: 46

Juvenile Nasopharyngeal Angiofibroma (JNA)

Categories: Rare diseases

Aliases & Classifications for Juvenile Nasopharyngeal Angiofibroma

MalaCards integrated aliases for Juvenile Nasopharyngeal Angiofibroma:

Name: Juvenile Nasopharyngeal Angiofibroma 59
Nasopharyngeal Angiofibroma 73
Jna 59

Characteristics:

Orphanet epidemiological data:

59
juvenile nasopharyngeal angiofibroma
Inheritance: Not applicable; Age of onset: Adolescent,Childhood;

Classifications:



External Ids:

Orphanet 59 ORPHA289596
ICD10 via Orphanet 34 D10.6
UMLS 73 C1367536

Summaries for Juvenile Nasopharyngeal Angiofibroma

MalaCards based summary : Juvenile Nasopharyngeal Angiofibroma, also known as nasopharyngeal angiofibroma, is related to familial adenomatous polyposis and vestibular gland benign neoplasm, and has symptoms including dyspnea, headache and tinnitus. An important gene associated with Juvenile Nasopharyngeal Angiofibroma is ESR1 (Estrogen Receptor 1), and among its related pathways/superpathways are Akt Signaling and Human cytomegalovirus infection. Affiliated tissues include endothelial, eye and retina, and related phenotypes are Increased cell death HMECs cells and hematopoietic system

Wikipedia : 76 Nasopharyngeal angiofibroma (also called juvenile nasopharyngeal angiofibroma) is a histologically... more...

Related Diseases for Juvenile Nasopharyngeal Angiofibroma

Diseases related to Juvenile Nasopharyngeal Angiofibroma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 125)
# Related Disease Score Top Affiliating Genes
1 familial adenomatous polyposis 10.3
2 vestibular gland benign neoplasm 10.3 ESR1 PGR
3 bartholin's gland adenoma 10.3 ESR1 PGR
4 vulvar syringoma 10.3 ESR1 PGR
5 glassy cell carcinoma of the cervix 10.3 ESR1 PGR
6 lung leiomyoma 10.3 ESR1 PGR
7 vulvar benign neoplasm 10.3 ESR1 PGR
8 trigonitis 10.3 ESR1 PGR
9 vulvar leiomyoma 10.3 ESR1 PGR
10 lymphangiomatosis 10.3 PCNA PGR
11 glomangiomyoma 10.2 ACTC1 ESR1
12 predominantly cortical thymoma 10.2 ESR1 PGR
13 breast medullary carcinoma 10.2 ESR1 PGR
14 breast scirrhous carcinoma 10.2 ESR1 PGR
15 scleromyxedema 10.2 ACTC1 FGF2
16 central retinal artery occlusion 10.2
17 retinal artery occlusion 10.2
18 bartholin's gland benign neoplasm 10.2 ESR1 PGR
19 calcifying aponeurotic fibroma 10.2 ACTC1 PGR
20 intravascular papillary endothelial hyperplasia 10.2 ACTC1 VEGFA
21 breast carcinoma in situ 10.2 ESR1 PGR VEGFA
22 angiodysplasia 10.2 ENG FGF2 VEGFA
23 malignant ovarian surface epithelial-stromal neoplasm 10.2 ESR1 PGR VEGFA
24 ovary epithelial cancer 10.2 ESR1 PGR VEGFA
25 oncocytic breast carcinoma 10.2 ESR1 PGR
26 angiomatous meningioma 10.2 FGF2 PGR VEGFA
27 bizarre leiomyoma 10.2 ACTC1 PCNA PGR
28 glycogen-rich clear cell breast carcinoma 10.2 ACTC1 ESR1 PGR
29 dupuytren contracture 10.2 BMP6 FGF2 VEGFA
30 ovarian fibrothecoma 10.2 ACTC1 KIT
31 progesterone resistance 10.2 ESR1 PGR
32 telangiectasis 10.2 BMP6 ENG VEGFA
33 glomeruloid hemangioma 10.2 ENG VEGFA
34 myxoid leiomyosarcoma 10.2 ACTC1 PGR
35 cribriform carcinoma 10.2 ESR1 KIT PGR
36 adenoid basal cell carcinoma 10.2 ESR1 KIT PGR
37 breast adenoid cystic carcinoma 10.2 ESR1 KIT PGR
38 peritoneal benign neoplasm 10.2 ESR1 KIT PGR
39 diffuse peritoneal leiomyomatosis 10.2 ESR1 KIT PGR
40 adenosarcoma 10.2 ESR1 KIT PGR
41 progesterone-receptor positive breast cancer 10.2 CYP19A1 ESR1 PGR
42 gender identity disorder 10.2 CYP19A1 ESR1 PGR
43 bone cancer 10.2 BMI1 ENG ESR1
44 estrogen excess 10.2 CYP19A1 ESR1 PGR
45 mammographic density 10.2 CYP19A1 ESR1 PGR
46 endometrial squamous cell carcinoma 10.2 ESR1 PGR
47 endometriosis of ovary 10.2 CYP19A1 ESR1 PGR
48 connective tissue cancer 10.1 FGF2 KIT VEGFA
49 endometrial adenocarcinoma 10.1 ESR1 FGF2 PGR VEGFA
50 meningioma, familial 10.1 ESR1 PCNA PGR VEGFA

Graphical network of the top 20 diseases related to Juvenile Nasopharyngeal Angiofibroma:



Diseases related to Juvenile Nasopharyngeal Angiofibroma

Symptoms & Phenotypes for Juvenile Nasopharyngeal Angiofibroma

UMLS symptoms related to Juvenile Nasopharyngeal Angiofibroma:


dyspnea, headache, tinnitus

GenomeRNAi Phenotypes related to Juvenile Nasopharyngeal Angiofibroma according to GeneCards Suite gene sharing:

26
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased cell death HMECs cells GR00103-A-0 9.17 BMI1 BMP6 ENG MYC PCNA PGR

MGI Mouse Phenotypes related to Juvenile Nasopharyngeal Angiofibroma:

46 (show all 20)
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.41 CYP11A1 CYP19A1 ENG ESR1 FGF2 KIT
2 cardiovascular system MP:0005385 10.4 ACTC1 CYP11A1 CYP19A1 ENG ESR1 FGF2
3 homeostasis/metabolism MP:0005376 10.4 ACTC1 CYP11A1 CYP19A1 ENG ESR1 FGF2
4 cellular MP:0005384 10.39 ACTC1 CYP11A1 CYP19A1 ESR1 FGF2 KIT
5 behavior/neurological MP:0005386 10.33 CYP11A1 CYP19A1 ENG ESR1 FGF2 KIT
6 immune system MP:0005387 10.32 CYP11A1 CYP19A1 ESR1 KIT MYC PCNA
7 mortality/aging MP:0010768 10.3 ACTC1 CYP11A1 ENG ESR1 FGF2 KIT
8 growth/size/body region MP:0005378 10.29 ACTC1 BMP6 CYP11A1 CYP19A1 ENG ESR1
9 digestive/alimentary MP:0005381 10.22 CYP19A1 ENG ESR1 KIT MYC PECAM1
10 endocrine/exocrine gland MP:0005379 10.21 CYP11A1 CYP19A1 ESR1 KIT MYC PCNA
11 muscle MP:0005369 10.21 ACTC1 CYP11A1 CYP19A1 ENG ESR1 FGF2
12 nervous system MP:0003631 10.07 CYP11A1 CYP19A1 ENG ESR1 FGF2 KIT
13 liver/biliary system MP:0005370 10.02 CYP11A1 CYP19A1 ESR1 KIT MYC PECAM1
14 normal MP:0002873 10.02 ACTC1 CYP11A1 CYP19A1 ENG ESR1 KIT
15 limbs/digits/tail MP:0005371 9.97 ESR1 KIT MYC PGR TGFB3 VEGFA
16 neoplasm MP:0002006 9.95 ESR1 FGF2 KIT MYC PGR TLR3
17 reproductive system MP:0005389 9.9 BMP6 CYP11A1 CYP19A1 ESR1 FGF2 KIT
18 renal/urinary system MP:0005367 9.8 CYP19A1 ESR1 KIT PECAM1 TLR7 TLR9
19 respiratory system MP:0005388 9.5 ENG ESR1 KIT PECAM1 TGFB3 TLR3
20 skeleton MP:0005390 9.32 BMP6 CYP19A1 ESR1 FGF2 KIT MYC

Drugs & Therapeutics for Juvenile Nasopharyngeal Angiofibroma

Search Clinical Trials , NIH Clinical Center for Juvenile Nasopharyngeal Angiofibroma

Genetic Tests for Juvenile Nasopharyngeal Angiofibroma

Anatomical Context for Juvenile Nasopharyngeal Angiofibroma

MalaCards organs/tissues related to Juvenile Nasopharyngeal Angiofibroma:

41
Endothelial, Eye, Retina, Bone, Ovary, Cervix, Smooth Muscle

Publications for Juvenile Nasopharyngeal Angiofibroma

Articles related to Juvenile Nasopharyngeal Angiofibroma:

(show top 50) (show all 451)
# Title Authors Year
1
Facial Palsy Following Embolization of a Juvenile Nasopharyngeal Angiofibroma. ( 29488393 )
2018
2
Differential Gene Expression and Pathway Analysis in Juvenile Nasopharyngeal Angiofibroma Using RNA Sequencing. ( 29634432 )
2018
3
Assisted resection of lateral extension of juvenile nasopharyngeal angiofibroma using a sphenopalatine fossa dissector. ( 29909791 )
2018
4
Juvenile Nasopharyngeal Angiofibroma With Sphenoid Sinus Invasion and Protrusion: Treatment Approach With Le Fort I Osteotomy. ( 29481518 )
2018
5
Cumulative sum analysis of the learning curve for endoscopic resection of juvenile nasopharyngeal angiofibroma. ( 29368283 )
2018
6
Hypoxia-Inducible Factor-1I+ (HIF-1I+) Expression on Endothelial Cells in Juvenile Nasopharyngeal Angiofibroma: A Review of 70 cases and Tissue Microarray Analysis. ( 29717655 )
2018
7
Juvenile Nasopharyngeal Angiofibroma: Combined Approach for Excision, Transpalatal and Endoscopic; A New Perspective. ( 29456956 )
2018
8
Endoscopic endonasal transmaxillary ligation of a feeding artery and coblation plasma technology enables en bloc resection of advanced juvenile nasopharyngeal angiofibroma without preoperative embolization. ( 29980404 )
2018
9
Juvenile Nasopharyngeal Angiofibroma: Our Experience in a Tertiary Hospital. ( 29977854 )
2018
10
Cerebrospinal Fluid Leak in Juvenile Nasopharyngeal Angiofibroma-Rare Sequelae of Flutamide-Induced Tumor Shrinkage. ( 30099189 )
2018
11
Juvenile nasopharyngeal angiofibroma: a single centre's 11-year experience. ( 30345941 )
2018
12
Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review. ( 30387011 )
2018
13
Morbidity and Volumetric Progression in Juvenile Nasopharyngeal Angiofibroma in a Long-Term Follow-Up. ( 30456021 )
2018
14
Transnasal microscopic approach for juvenile nasopharyngeal angiofibroma. ( 30460914 )
2018
15
Comparative Study between Conventional Method and Endonasal Endoscopic Resection of Juvenile Nasopharyngeal Angiofibroma. ( 30487495 )
2018
16
Patterns of vascularization and surgical morbidity in juvenile nasopharyngeal angiofibroma: A case series, systematic review, and meta-analysis. ( 29130560 )
2018
17
Management and Outcome in Patients with Advanced Juvenile Nasopharyngeal Angiofibroma. ( 30009116 )
2018
18
Juvenile nasopharyngeal angiofibroma surgical treatment in paediatric patients. ( 30093086 )
2018
19
Radiation-Induced Sarcoma Originating in Recurrent Juvenile Nasopharyngeal Angiofibroma. ( 30123593 )
2018
20
Clinical correlation of molecular (VEGF, FGF, PDGF, c-Myc, c-Kit, Ras, p53) expression in juvenile nasopharyngeal angiofibroma. ( 30171340 )
2018
21
Nasopharyngeal Angiofibroma: A Clinical, Histopathological and Immunohistochemical Study of 42 Cases with Emphasis on Stromal Features. ( 28508272 )
2018
22
A rare case of extra-nasopharyngeal angiofibroma of the septum in a female child. ( 29143693 )
2018
23
Nasopharyngeal angiofibroma in a 32-year-old man. ( 29437803 )
2018
24
A case of nasopharyngeal angiofibroma removed using a minimally invasive endoscopic endonasal technique. ( 30524630 )
2018
25
Nasopharyngeal angiofibroma in an elderly female patient: A rare case report. ( 30546905 )
2018
26
Massive juvenile nasopharyngeal angiofibroma: ode to the open surgical approach. ( 28765177 )
2017
27
Juvenile Nasopharyngeal Angiofibroma: A Case Report. ( 28571176 )
2017
28
Perioperative airway management of a 16-year-old boy with progressive airway obstruction due to juvenile nasopharyngeal angiofibroma. ( 28781841 )
2017
29
Variable expression of molecular markers in juvenile nasopharyngeal angiofibroma. ( 28683841 )
2017
30
Complications of Midface Swing for Management of Juvenile Nasopharyngeal Angiofibroma. ( 28286392 )
2017
31
Reassessing the Anatomic Origin of the Juvenile Nasopharyngeal Angiofibroma. ( 28632604 )
2017
32
Trigeminocardiac reflex during endoscopic juvenile nasopharyngeal angiofibroma surgery: an appraisal. ( 28324181 )
2017
33
Imaging in Juvenile Nasopharyngeal Angiofibroma: Clinical Significance of Ramharan and Chopstick Sign. ( 28239585 )
2017
34
Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma. ( 28707818 )
2017
35
Nasopharyngeal angiofibroma in an adult with Proteus syndrome. First reported case. ( 30479478 )
2017
36
Efficacy of Preoperative Transcatheter Arterial Embolization for Nasopharyngeal Angiofibroma: A Comparative Study. ( 28175976 )
2017
37
Nasopharyngeal Angiofibroma: Paradigm Shift in Management. ( 28239578 )
2017
38
Extra Nasopharyngeal Angiofibroma Simulating a Mucocele: A New Location for the Rare Entity. ( 28274071 )
2017
39
Changing trends in the incidence of juvenile nasopharyngeal angiofibroma: seven decades of experience at King George's Medical University, Lucknow, India. ( 26864451 )
2016
40
Adjunctive Treatment in Juvenile Nasopharyngeal Angiofibroma: How Should We Approach Recurrence? ( 26907644 )
2016
41
Juvenile nasopharyngeal angiofibroma. ( 27601836 )
2016
42
Human Papilloma virus in Juvenile Nasopharyngeal Angiofibroma: possible recent trend. ( 27157983 )
2016
43
Current molecular profile of juvenile nasopharyngeal angiofibroma: First comprehensive study from India. ( 27577998 )
2016
44
Multiport Combined Endoscopic Approach to Nonembolized Juvenile Nasopharyngeal Angiofibroma with Parapharyngeal Extension: An Emerging Concept. ( 28101106 )
2016
45
Time trends in recurrence of juvenile nasopharyngeal angiofibroma: Experience of the past 4 decades. ( 27178522 )
2016
46
Juvenile Nasopharyngeal Angiofibroma. ( 27164528 )
2016
47
In defence of transpalatal, transpalatal-circumaxillary (transpterygopalatine) and transpalatal-circumaxillary-sublabial approaches to lateral extensions of juvenile nasopharyngeal angiofibroma. ( 26940398 )
2016
48
The isolation and characterization of endothelial cells from juvenile nasopharyngeal angiofibroma. ( 27421657 )
2016
49
Juvenile Nasopharyngeal Angiofibroma: A Rise in Incidence. ( 27340627 )
2016
50
Association between vascular supply, stage and tumour size of juvenile nasopharyngeal angiofibroma. ( 27289235 )
2016

Variations for Juvenile Nasopharyngeal Angiofibroma

Expression for Juvenile Nasopharyngeal Angiofibroma

Search GEO for disease gene expression data for Juvenile Nasopharyngeal Angiofibroma.

Pathways for Juvenile Nasopharyngeal Angiofibroma

Pathways related to Juvenile Nasopharyngeal Angiofibroma according to GeneCards Suite gene sharing:

(show all 32)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.32 BMP6 FGF2 KIT TGFB3 TLR3 TLR7
2
Show member pathways
12.96 FGF2 MYC PCNA TGFB3 TLR3 VEGFA
3
Show member pathways
12.79 KIT MYC PCNA TGFB3 VEGFA
4 12.68 FGF2 KIT MYC TGFB3 VEGFA
5 12.65 ESR1 FGF2 KIT MYC TGFB3 VEGFA
6
Show member pathways
12.51 ESR1 FGF2 KIT MYC PGR TGFB3
7 12.42 KIT PECAM1 TLR3 TLR7 TLR9
8
Show member pathways
12.32 TLR3 TLR7 TLR9 VEGFA
9
Show member pathways
12.25 BMP6 FGF2 TGFB3 TLR3 TLR7 TLR9
10 12.21 ESR1 FGF2 MYC VEGFA
11
Show member pathways
12.13 BMP6 FGF2 KIT MYC TGFB3
12 12.04 CYP19A1 ESR1 MYC VEGFA
13 11.92 BMI1 FGF2 MYC VEGFA
14 11.89 FGF2 MYC VEGFA
15
Show member pathways
11.89 TGFB3 TLR3 TLR7 TLR9
16 11.75 TLR3 TLR7 TLR9
17 11.74 BMP6 MYC TGFB3
18 11.7 BMI1 FGF2 VEGFA
19 11.69 ENG ESR1 MYC TGFB3
20 11.67 KIT TLR7 TLR9
21 11.6 BMP6 FGF2 VEGFA
22
Show member pathways
11.59 ESR1 KIT MYC VEGFA
23 11.51 ENG FGF2 PECAM1 TGFB3
24 11.49 ACTC1 FGF2 KIT
25 11.45 PECAM1 TGFB3 TLR9
26 11.44 BMP6 CYP11A1 CYP19A1
27 11.42 ESR1 MYC VEGFA
28 11.34 FGF2 MYC VEGFA
29 11.32 MYC TGFB3 TLR3 TLR7 TLR9 VEGFA
30 11.02 FGF2 TGFB3 VEGFA
31 10.94 FGF2 KIT TGFB3 VEGFA
32 10.16 CYP19A1 ESR1

GO Terms for Juvenile Nasopharyngeal Angiofibroma

Cellular components related to Juvenile Nasopharyngeal Angiofibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.72 ENG KIT TGFB3 TLR3 VEGFA
2 extracellular space GO:0005615 9.61 ACTC1 BMP6 ENG FGF2 KIT PECAM1
3 early phagosome GO:0032009 9.16 TLR7 TLR9
4 endolysosome membrane GO:0036020 8.8 TLR3 TLR7 TLR9
5 cytoplasm GO:0005737 10.07 ACTC1 BMI1 BMP6 ESR1 KIT MYC

Biological processes related to Juvenile Nasopharyngeal Angiofibroma according to GeneCards Suite gene sharing:

(show all 46)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of cell proliferation GO:0008284 9.99 BMP6 FGF2 KIT MYC TGFB3 VEGFA
2 cytokine-mediated signaling pathway GO:0019221 9.98 FGF2 KIT MYC VEGFA
3 inflammatory response GO:0006954 9.98 BMP6 KIT TLR3 TLR7 TLR9
4 angiogenesis GO:0001525 9.96 ENG FGF2 PECAM1 VEGFA
5 positive regulation of protein kinase B signaling GO:0051897 9.9 ENG ESR1 FGF2 KIT
6 negative regulation of gene expression GO:0010629 9.88 ENG ESR1 MYC PGR VEGFA
7 phosphatidylinositol phosphorylation GO:0046854 9.87 ESR1 FGF2 KIT
8 response to estradiol GO:0032355 9.86 ESR1 MYC PCNA
9 male gonad development GO:0008584 9.86 ESR1 KIT TLR3
10 wound healing GO:0042060 9.85 FGF2 PECAM1 TGFB3
11 positive regulation of angiogenesis GO:0045766 9.85 ENG FGF2 TLR3 VEGFA
12 positive regulation of inflammatory response GO:0050729 9.84 TLR3 TLR7 TLR9
13 positive regulation of endothelial cell proliferation GO:0001938 9.83 BMP6 FGF2 VEGFA
14 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.82 KIT PECAM1 VEGFA
15 I-kappaB kinase/NF-kappaB signaling GO:0007249 9.81 TLR3 TLR7 TLR9
16 positive regulation of epithelial cell proliferation GO:0050679 9.81 BMP6 MYC VEGFA
17 positive regulation of MAP kinase activity GO:0043406 9.8 FGF2 KIT VEGFA
18 positive regulation of interleukin-6 production GO:0032755 9.79 TLR3 TLR7 TLR9
19 positive regulation of fibroblast proliferation GO:0048146 9.79 BMI1 ESR1 MYC
20 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.78 TLR3 TLR7 TLR9
21 positive regulation of pathway-restricted SMAD protein phosphorylation GO:0010862 9.77 BMP6 ENG TGFB3
22 positive regulation of cell division GO:0051781 9.75 FGF2 TGFB3 VEGFA
23 ovarian follicle development GO:0001541 9.73 KIT MYC VEGFA
24 cellular response to mechanical stimulus GO:0071260 9.73 BMP6 ENG TLR3 TLR7
25 toll-like receptor signaling pathway GO:0002224 9.71 TLR3 TLR7 TLR9
26 androgen metabolic process GO:0008209 9.7 CYP19A1 ESR1
27 mammary gland development GO:0030879 9.7 CYP19A1 PGR TGFB3
28 positive regulation of gene expression GO:0010628 9.7 ACTC1 ENG KIT MYC TLR3 TLR9
29 mammary gland alveolus development GO:0060749 9.69 ESR1 VEGFA
30 toll-like receptor 9 signaling pathway GO:0034162 9.69 TLR7 TLR9
31 cellular response to estrogen stimulus GO:0071391 9.68 ESR1 MYC
32 positive regulation of DNA biosynthetic process GO:2000573 9.68 FGF2 MYC
33 positive regulation of SMAD protein signal transduction GO:0060391 9.67 BMP6 TGFB3
34 positive regulation of interleukin-8 production GO:0032757 9.67 TLR3 TLR7 TLR9
35 positive regulation of interleukin-8 biosynthetic process GO:0045416 9.66 TLR7 TLR9
36 positive regulation of vascular smooth muscle cell differentiation GO:1905065 9.64 ENG KIT
37 positive regulation of chemokine production GO:0032722 9.63 TLR3 TLR7 TLR9
38 paracrine signaling GO:0038001 9.62 FGF2 PGR
39 positive regulation of interferon-gamma biosynthetic process GO:0045078 9.58 TLR3 TLR7 TLR9
40 positive regulation of toll-like receptor signaling pathway GO:0034123 9.57 TLR3 TLR9
41 positive regulation of phospholipase C activity GO:0010863 9.54 ESR1 FGF2 KIT
42 I-kappaB phosphorylation GO:0007252 9.5 TLR3 TLR7 TLR9
43 positive regulation of interferon-beta biosynthetic process GO:0045359 9.43 TLR3 TLR7 TLR9
44 positive regulation of transcription by RNA polymerase II GO:0045944 9.32 BMP6 ENG ESR1 FGF2 MYC PGR
45 positive regulation of interferon-alpha biosynthetic process GO:0045356 9.13 TLR3 TLR7 TLR9
46 signal transduction GO:0007165 10.25 ESR1 FGF2 KIT PECAM1 PGR TLR3

Molecular functions related to Juvenile Nasopharyngeal Angiofibroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.62 BMP6 FGF2 TGFB3 VEGFA
2 phosphatidylinositol-4,5-bisphosphate 3-kinase activity GO:0046934 9.54 ESR1 FGF2 KIT
3 identical protein binding GO:0042802 9.5 ENG ESR1 PCNA PGR TGFB3 TLR3
4 type I transforming growth factor beta receptor binding GO:0034713 9.46 ENG TGFB3
5 growth factor activity GO:0008083 9.46 BMP6 FGF2 TGFB3 VEGFA
6 signaling pattern recognition receptor activity GO:0008329 9.43 TLR7 TLR9
7 siRNA binding GO:0035197 9.4 TLR7 TLR9
8 type II transforming growth factor beta receptor binding GO:0005114 9.26 ENG TGFB3
9 transmembrane signaling receptor activity GO:0004888 9.02 ENG KIT TLR3 TLR7 TLR9

Sources for Juvenile Nasopharyngeal Angiofibroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....